Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2026
Nasdaq grants Evogene additional 180-day period to regain minimum bid price compliance
Evogene reported that Nasdaq granted the company an additional 180-day period to regain compliance with the exchange's minimum bid price requirement.
2020
Evogene raises $12 million in equity
Evogene raised $12 million in equity on November 4, 2020, as part of two fundraising rounds totaling $22 million.
2020
Evogene announces new corporate branding
Evogene announced its rebranding and new corporate identity, which it said reflects the company's expanded vision and new business model.
2019
Evogene reports third-quarter 2019 financial results
Evogene announced its financial results for the third quarter ending September 30, 2019, including revenue of $0.1 million and a net loss of $4.5 million.
2019
Corteva invests in Lavie Bio
Corteva invested $10 million in equity in Lavie Bio and transferred its holdings in Taxon Biosciences; after the investment, Corteva held approximately 30% of Lavie Bio and Evogene approximately 70%.